Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Annovis Bio Stock News

ANVSNYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Q4 2024 Earnings were released on Fri Mar 21st, after the market close

Annovis Bio (ANVS) Forecast

News

Earnings Annovis Bio (ANVS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Annovis Bio Stock News | NYSE:ANVS | Benzinga

Get the latest news on Annovis Bio stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Annovis Bio performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, March 24, 2025

Reported Friday, Annovis Bio Q4 2024 GAAP EPS...
Benzinga Newsdesk

Monday, February 10, 2025

Annovis Bio shares are trading lower after D....
Benzinga Newsdesk
D. Boral Capital Downgrades Annovis Bio to Ho...
Benzinga Newsdesk

Wednesday, February 05, 2025

Annovis Bio Announces That The First Two Pati...
Benzinga Newsdesk

Monday, February 03, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Annovis Bio shares are trading lower after th...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Annovis Bio Prices $21M Public Offering Of 5....
Benzinga Newsdesk
Reported Friday, Annovis Bio Proposed Public ...
Benzinga Newsdesk

Tuesday, January 14, 2025

Annovis Bio Granted U.S. Patent For Buntaneta...
Benzinga Newsdesk

Tuesday, January 07, 2025

Annovis Bio Announces The FDA Has Accepted An...
Benzinga Newsdesk

Monday, November 11, 2024

D. Boral Capital Maintains Buy on Annovis Bio...
Benzinga Newsdesk
Annovis Bio shares are trading lower after th...
Benzinga Newsdesk
Annovis Bio Q3 EPS $(0.97) Misses $(0.38) Est...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk

Wednesday, October 16, 2024

Annovis Bio shares are trading higher. HC Wai...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk

Tuesday, October 15, 2024

EF Hutton Maintains Buy on Annovis Bio, Maint...
Benzinga Newsdesk
Annovis Bio shares are trading higher after t...
Benzinga Newsdesk
FDA Clears Annovis To Begin Pivotal Phase 3 A...
Benzinga Newsdesk

Tuesday, October 01, 2024

HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk

Monday, September 30, 2024

Annovis Files Three New Patents For Combinati...
Benzinga Newsdesk

Thursday, August 15, 2024

EF Hutton Maintains Buy on Annovis Bio, Maint...
Benzinga Newsdesk
Annovis Bio shares are trading higher. The co...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk
Annovis Bio Q2 2024 GAAP EPS $(0.44) Misses $...
Benzinga Newsdesk

Tuesday, August 13, 2024

EF Hutton Initiates Coverage On Annovis Bio w...
Benzinga Newsdesk

Thursday, August 08, 2024

Editas Q2 Earnings & Revenues Miss Estimates, Stock Down
Zacks

Tuesday, August 06, 2024

Annovis Announces Preclinical Data Demonstrat...
Benzinga Newsdesk

Wednesday, July 24, 2024

Annovis Bio Secures U.S. Patent For Treatment...
Benzinga Newsdesk

Wednesday, July 17, 2024

HC Wainwright & Co. Reiterates Buy on Annovis...
Benzinga Newsdesk

Tuesday, July 16, 2024

Annovis Bio Granted FDA Approval To Transitio...
Benzinga Newsdesk

Monday, July 15, 2024

Immutep Up as Combo Therapy Meets Carcinoma Study Goals
Zacks

Thursday, July 11, 2024

Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Annovis ...
Benzinga Newsdesk

Wednesday, July 10, 2024

UniQure Soars on New Huntington's Disease Study Data
Zacks
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor

Tuesday, July 09, 2024

Annovis Bio Shares Resume Trade
Benzinga Newsdesk
Annovis Shares Halted On Circuit Breaker To D...
Benzinga Newsdesk

Friday, July 05, 2024

Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor

Wednesday, July 03, 2024

Peering Into Annovis Bio's Recent Short Interest
Benzinga Insights
What's Going On With Annovis Shares Today?
Nabaparna Bhattacharya
Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
Benzinga Neuro

Tuesday, July 02, 2024

Annovis Bio Shares Halted On Circuit Breaker ...
Benzinga Newsdesk
Rodman & Renshaw Reiterates Buy on Annovis Bi...
Benzinga Newsdesk
What's Going With Annovis Bio Shares Tuesday?
Dylan Berman
Annovis Bio Announces Phase III Study Results...
Benzinga Newsdesk

Friday, June 28, 2024

Merck's New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
Zacks

Thursday, June 27, 2024

Novo Nordisk's Hypertension Drug Study Fails to Meet Goal
Zacks
Annovis Bio Files Provisional Patent For New ...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved